Pre-launch · We're opening Reserve Meds to a limited first cohort. Join the waitlist ›

Is Brinsupri available in India?

Brinsupri access status in India via the Named Patient Program, registered-pathway status, and next steps.

On pricing. We do not publish drug-specific list prices. Every case is quoted individually, and the quote covers manufacturer list, documented duty at destination, cold-chain logistics, and our coordination fee. For indicative ranges by therapy category, see what to expect on cost. For a case-specific quote, begin a consultation.

YELLOW
AI Regulatory Review Agent, preliminary signal
Brinsupri (brensocatib) is an oral small molecule recently approved by the US FDA; international supply follows named-patient pathway depending on jurisdiction. No cold-chain handling needed. Typical regulatory turnaround 2-4 weeks.
Rule: sm_specialty_clear_pathway • Reviewed 2026-04-22

Indicative landed pricing

Quote-only. Public US wholesale acquisition cost is not disclosed for this medication, so we do not publish an indicative landed range. Reserve Meds quotes each case after a brief intake.

Therapeutic-class fallback band (very wide): USD 3,375-47,250 per month. This is a category-level placeholder, not a drug-specific number. Actual landed cost depends on dose, cycle count, destination duty regime, and current sourcing conditions.

Indicative only, not a quote. Get a case-specific quote

How Reserve Meds helps patients in India

  1. Intake: Submit the 60-second request, drug, country, prescription status.
  2. Physician verification: Our clinical team verifies the prescription with your treating physician.
  3. Regulatory documentation: We prepare the named-patient / personal-import paperwork for India (CDSCO).
  4. US sourcing: Reserve Meds sources Brinsupri from DSCSA-compliant US specialty wholesalers.
  5. Secure delivery: Validated cold-chain (where required) to destination, with temperature logs.

Start your request · Brinsupri drug page · India country page

Frequently asked

Is this legal?

Yes, India recognizes named-patient / personal-import pathways for drugs not locally registered. Reserve Meds coordinates through our wholesale pharmacy partner, a US-licensed specialty wholesaler, while we complete our own wholesale distributor license and direct manufacturer relationships.

How long does it take?

Typical timeline: 2-4 weeks for small-molecule oral therapies, 4-8 weeks for biologics, 6-12 weeks for cell/gene therapies.

Can my doctor start the request?

Yes, your prescribing physician can submit on your behalf. Route to the intake form and select "Healthcare professional".

Important. Reserve Meds is a coordination service for international patients seeking US-sourced medicines on a cash-pay basis. We are not a pharmacy, not a prescriber, and do not dispense medicines. Eligibility, regulatory pathway, and final price are determined per case after physician verification and documentation review.

Composite cases. Any patient story or example on Reserve Meds is a composite based on multiple real situations, with all identifying details changed. No content is medical advice.

By using this service you agree to Terms of Service, Privacy Policy, and the Cross-Border Disclosures.

AI disclosure & medical review. Content on this page is reviewed by Reserve Meds's clinical and regulatory team. Last medically reviewed: .